Status:
COMPLETED
Helichrysum Italicum Infusion Ingestion in Humans
Lead Sponsor:
University of Primorska
Conditions:
Energy Expenditure
Substrate Oxidation
Eligibility:
MALE
18-45 years
Phase:
NA
Brief Summary
The study evaluates the acute effects of Helichrysum italicum on resting energy expenditure and substrate oxidation in humans. The resting energy expenditure and substrate oxidation will be measured b...
Detailed Description
Bioactive compounds found in medicinal plants and plant extracts, such as polyphenols, represent the oldest and most widely used form of alternative or complementary treatments for the prevention and ...
Eligibility Criteria
Inclusion
- healthy, weight-stable (±3 kg in the last 3 months), normotensive, non-smokers, no use of dietary supplements or frequent use of medication and no known metabolic disorders.
Exclusion
- females, smoking, medications, dietary supplements, metabolic diseases, hypertensive
Key Trial Info
Start Date :
June 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
11 Patients enrolled
Trial Details
Trial ID
NCT04818905
Start Date
June 15 2020
End Date
September 30 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Primorska, Faculty of Health Sciences
Izola, Slovenia, 6310